Skip to content
ES
MARKETS / NYSE / ASH
NYSE · WHOLESALE-CHEMICALS & ALLIED PRODUCTS · LARGE CAP

Ashland Inc. ASH

12 fiscal years on record · USD · FY2025 reported · SEC filings only
7 YEARS OF DIVIDEND GROWTH
$1.8B
▼ 13.7% YoY
$-845.0M
▼ 600.0% YoY
$36.0M
▼ 88.9% YoY
In brief

What this company does

It has approximately 2,900 employees worldwide and serves customers in more than 100 countries. Its reportable operating segments are Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is comprised of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment is comprised of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment is comprised of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment is comprised of the production of 1,4 butanediol (BDO) and related derivatives, including n-methylpyrrolidone.

Written from the business description in ASHLAND INC.'s annual report to the U.S. Securities and Exchange Commission, filed 20 November 2025. Every sentence was checked against that document before publication.

Growth
USD 1.8B
Revenue, FY2025 · full 12-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.8 · Net income -0.8
2.5B5.0B-0.4B-0.8B2014201620182020202220242025
Compound annual growth
−8.6%
−2.0%
−6.1%
+8.9%
+8.3%
+1.2%
−13.3%
+21.7%
−9.8%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −2.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−46 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -42.5% · Net -46.3%
10%20%30%-20%-40%2014201620182020202220242025
ROE
FY2019 · ROE 14.5%
5%10%2014201620182020202220242025
Gross margin30.1%
Operating margin-42.5%
Net margin-46.3%
Return on assets-16.5%
EBITDAUSD -538.0M

Cash & shareholders
USD 176.0M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 36.0
200M-200M-400M2014201620182020202220242025
Net buybacks $M Dividends $M
FY2025 · Dividends 76.0 · Net buybacks 100.0
400M800MDividendsNet buybacks2014201620182020202220242025
Dividends paidUSD 76.0M
Net buybacksUSD 100.0M
Share of profit—
Consecutive raises7 years

USD 76.0M in dividends and USD 100.0M in buybacks went back to shareholders.

Total assetsUSD 4.6B
EquityUSD 1.9B
CashUSD 215.0M
Gross debtUSD 1.4B
Net debtUSD 1.2B
Current ratio2.85×

Net debt stands at 61% of equity.

The 12-year record
12 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 202520242023202220212020201920182017201620152014
Revenue $B1.82.12.22.42.12.02.12.62.33.03.46.1
Operating income $B−0.8−0.00.20.30.2−0.50.10.10.0−0.10.10.0
EBITDA $B−0.50.20.40.60.4−0.20.40.40.30.30.40.4
Income tax $B0.0−0.2−0.00.0−0.0−0.00.0−0.0−0.0−0.0−0.1−0.2
Net income $B−0.80.20.20.90.2−0.50.50.10.0−0.00.30.2
Free cash flow $B0.00.30.10.10.40.1−0.00.10.00.2−0.50.3
EPS, diluted $−18.233.363.3116.413.59−8.398.151.790.01−0.474.543.00
Dividend / sh $1.641.581.441.271.151.101.050.951.231.561.461.36
Payout %······13537700−3343244
ROE %······14.53.30.0−0.910.2·
Shares out B·····0.060.060.060.060.060.07·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 58 reconciliationsAUDITED

Reconciled in 12 of 19 fiscal years. 37 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityWholesale-Chemicals & Allied Products
Listed onNYSE
Incorporated inDelaware
Fiscal year endsSeptember 30
Data on record since2014

Share this section

Download image